GHRP-6: Handling, Storage, and Reconstitution Guide

Careful handling protects two things at once. It protects the integrity of a synthetic peptide. It also protects the repeatability of every experiment that depends on it. This guide covers GHRP-6 handling, storage, and reconstitution as lab practice. It is written for trained staff working under institutional protocols. It describes in vitro and preclinical prep only.

What are the GHRP-6 specifications, and what arrives in the vial?

GHRP-6 is a synthetic hexapeptide, a chain of six amino acids. Its key identifiers are:

• Sequence: His-D-Trp-Ala-Trp-D-Phe-Lys-NH2
• Molecular formula: C46H56N12O6
• Molecular weight: about 873.01 g/mol
• CAS number: 87616-84-0
• PubChem CID: 4345065

In the literature it also appears as Growth Hormone Releasing Peptide-6 and SKF-110679. These identifiers matter at intake. They are what a certificate of analysis is checked against.

The material is a solid white lyophilized (freeze-dried) powder in a sealed glass vial. Puritide Research supplies it as a US-made, research-grade peptide. It comes at 99 percent or greater purity in a 10mg vial. Each batch has documents checked by a third party. Full specs are on the GHRP-6 10mg research vial product page.

How should lyophilized GHRP-6 powder be stored?

Store the powder at or below 25C, sealed, and protected from heat, light, and moisture. For long storage, keep it as powder and refrigerate or freeze it.

• Store sealed vials at or below 25C, away from direct light and heat.
• Move to refrigerated or frozen storage for long holding.
• Keep the vial sealed until prep is actually needed.
• Let a chilled vial reach room temperature before opening, so no condensation forms on the cake.
• Keep conditions steady across the study, and log storage records for quality checks.

Moisture is the quiet failure mode. Lyophilized powder is hygroscopic, which means it pulls water from the air. Opening a cold vial in a humid room puts water onto the cake. That undoes the stability benefit of the dry form.

How are GHRP-6 lot documents and the COA verified?

Check the material against its paperwork before any prep. Each batch ships with a certificate of analysis (COA) checked by a third party. It reports:

• Purity by HPLC or reverse-phase chromatography
• Identity confirmed by mass spectrometry
• The lot number and testing date
• The analytical methods used

Sample certificates can be requested before purchase.

Verifying means checking, not filing. Confirm that the reported purity meets the stated spec. Confirm that the mass spec result fits a molecular weight near 873.01 g/mol for this sequence. Confirm that the lot number matches the vial in hand. Independent testing is encouraged where a lab can do it.

Record the lot at intake. Carry it through every later record. That field later links a result back to one batch with documented purity and identity.

How is GHRP-6 reconstituted for in vitro preparation?

When a protocol calls for a solution, reconstitution is commonly done with bacteriostatic water. This is a lab prep step. Some protocols use sterile water or a buffer that suits the assay. That choice belongs to the protocol. None of it describes administration of any kind.

The technique is simple, and it is worth doing with care:

• Add the diluent slowly down the inner wall of the vial, not onto the cake.
• Swirl gently and let the powder dissolve on its own.
• Do not shake hard or vortex strongly.
• Check that the powder is fully dissolved and the solution is clear, with no visible particles.

Hard shaking and foaming at the air surface add mechanical stress. That stress promotes breakdown and clumping.

Set the reconstitution volume from two numbers. One is the working strength the assay needs. The other is the 10mg of peptide in the vial. That way, stock strength is a deliberate choice rather than a habit.

How are GHRP-6 aliquots prepared to avoid freeze-thaw cycles?

Reconstituted peptide is much less stable than the powder. Repeated freeze-thaw cycles are the most common avoidable cause of breakdown in solution. The fix is to split the stock into single-use aliquots right after prep. Each experiment then draws a fresh portion. No shared tube gets thawed again and again.

• Size each portion to a single experiment, with no plan to refreeze.
• Label tubes with compound, lot number, concentration, and prep date.
• Store aliquots cold per protocol, and keep solutions chilled during use.
• Keep time at room temperature and light exposure to a minimum.
• Use solutions within the protocol window rather than holding them without limit.

Aliquoting also improves tracing. A labeled single-use tube shows which lot and prep date produced a given data point. That is hard to work out after a shared stock has been drawn from a dozen times.

What protective equipment and institutional controls apply?

Handle GHRP-6 as what it is. It is an investigational synthetic peptide for lab use only. It should be handled by trained staff under institutional policy.

• Follow standard operating procedures and the site chemical hygiene plan.
• Wear a lab coat, gloves, and eye protection.
• Use engineering controls, such as a fume hood or biosafety cabinet, where local rules require them.

Weighing and moving a dry powder is the step most likely to put material into the air. So it needs the most containment. A dedicated prep area also cuts cross-contamination when several peptides are in use at once.

Why do documentation and traceability matter in comparative work?

A steady log gives a lab a sound chain of custody. The log should cover receipt, storage, reconstitution, and aliquoting. Keep COAs and batch documents with it. Then everything a collaborator or auditor might ask for is in one place.

This matters most in comparative studies. GHRP-6 anchors panels that also run GHRP-2 as a hexapeptide comparator and ipamorelin as the selective agonist reference. If handling adds variability in one arm, it quietly distorts the whole comparison.

Labs usually apply one written procedure across compounds. The same rules extend to GHRP-2 preparation and ipamorelin preparation. This is set out alongside the GHRP-2 versus GHRP-6 comparison.

Prep quality feeds into how data are read. Activity depends on intact peptide reaching the receptor, as the GHRP-6 mechanism of action overview explains. Degraded material shows up as a shifted potency value, not an obvious error. The designs in the GHRP-6 research applications survey only hold together when the input material is controlled.

Common research questions about GHRP-6 handling

What is used to reconstitute GHRP-6 for laboratory work?

Bacteriostatic water is the usual choice for in vitro prep. Sterile water or an assay-suitable buffer is used where a protocol calls for it. The diluent is added gently down the vial wall. The vial is swirled, not shaken.

How should lyophilized and reconstituted material be stored differently?

The powder is stored sealed at or below 25C, away from heat, light, and moisture. It is refrigerated or frozen for long holding. The solution is far less stable. So it is kept cold, split into single-use aliquots, and used within the protocol window. It is not frozen and thawed again and again.

What should be checked on the certificate of analysis?

Confirm the lot number matches the vial. Check that HPLC or reverse-phase purity meets the stated spec. Check that mass spec identity fits the expected sequence and a molecular weight near 873.01 g/mol. Confirm that the testing date and methods are documented.

For research use only. Not for human or veterinary use. All handling, storage, and reconstitution guidance above describes laboratory best practice for in vitro and preclinical research, and is not administration guidance of any kind.